<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572966/" ref="ordinalpos=4611&amp;ncbi_uid=4671421&amp;link_uid=PMC3572966" image-link="/pmc/articles/PMC3572966/figure/pone-0056891-g005/" class="imagepopup">Figure 5. ERK1/2 is the predominant <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> facilitating IL-1β-mediated astrocyte TIMP-1 expression..  From: Extracellular Regulated Kinase 1/2 <span class="highlight" style="background-color:">Signaling</span> Is a Critical Regulator of Interleukin-1?-Mediated Astrocyte Tissue Inhibitor of Metalloproteinase-1 Expression. </a></div><br /><div class="p4l_captionBody">Neuroinflammation activates bystander microglia and astrocytes to secrete IL-1β. Astrocytes respond to IL-1β by secreting TIMP-1. In this study we use a panel of small molecule pathway-selective inhibitors to delineate the signal transduction mechanism facilitating IL-1β-induced astrocyte TIMP-1 expression. p38K- and ERK1/2-selective inhibitors reduced and completely blocked IL-1β-induced astrocyte TIMP-1 mRNA and protein expression, respectively. U0126, the ERK1/2-selective inhibitor, also blocked TIMP-1 promoter activity.</div></div>